Mario Witkowski
Impact in
-
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
Papers in ⓘ
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 2
-
- IL-33, ST2, and ILC Pathways 3
- Co-authors
- Caroline Tizian (3 shared papers)Marco Witkowski (5 shared papers)Hansruedi Glatt (1 shared paper)Lukas Amann (1 shared paper)Jakob Zimmermann (1 shared paper)Fabian Schumacher (1 shared paper)Antigoni Triantafyllopoulou (1 shared paper)Konrad Gronke (1 shared paper)
- Journals
- Cardiovascular Diabetology (2 papers)Nature Communications (1 paper)Cardiovascular Research (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (1 paper)Nature (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Mario Witkowski
11 papers receiving 543 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Immunology 200
- Biological Psychiatry 20
- Cancer Research 77
- Internal Medicine 14
- Molecular Biology 240
Countries citing papers authored by Mario Witkowski
This map shows the geographic impact of Mario Witkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Witkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Witkowski more than expected).
Fields of papers citing papers by Mario Witkowski
This network shows the impact of papers produced by Mario Witkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Witkowski. The network helps show where Mario Witkowski may publish in the future.
Co-authors
The 25 scholars most cited alongside Mario Witkowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Interleukin-22 protects intestinal stem cells against genotoxic stress Hit paper breakdown → | 2019 | 272 |
| 2 | 2021 | 72 | |
| 3 | 2016 | 72 | |
| 4 | 2020 | 37 | |
| 5 | 2017 | 31 | |
| 6 | 2018 | 28 | |
| 7 | 2010 | 17 | |
| 8 | 2025 | 6 | |
| 9 | 2023 | 6 | |
| 10 | 2024 | 5 | |
| 11 | 2012 | 1 | |
| 12 | 2025 | 0 |
About Mario Witkowski
Mario Witkowski is a scholar working on Cancer Research, Immunology, Gastroenterology, Hematology and Infectious Diseases, having authored 12 papers that have together received 547 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), IL-33, ST2, and ILC Pathways (3 papers), MicroRNA in disease regulation (2 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Gut microbiota and health (2 papers), Circular RNAs in diseases (1 paper) and Mesenchymal stem cell research (1 paper). The work is most often cited by research in Immunology (200 citations), Biological Psychiatry (20 citations), Cancer Research (77 citations), Internal Medicine (14 citations) and Molecular Biology (240 citations). Mario Witkowski has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Caroline Tizian, Marco Witkowski, Hansruedi Glatt, Lukas Amann, Jakob Zimmermann, Fabian Schumacher, Antigoni Triantafyllopoulou, Konrad Gronke, Pedro P. Hernández and Christoph S. N. Klose. Their work appears in journals such as Cardiovascular Diabetology, Nature Communications, Cardiovascular Research, Arteriosclerosis Thrombosis and Vascular Biology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.